Home / Science / Rapamycin: The Anti-Aging Drug?
Rapamycin: The Anti-Aging Drug?
13 Apr
Summary
- Rapamycin, a transplant drug, is explored for anti-aging.
- Animal studies show lifespan extension, human data is early.
- Unsupervised use carries significant health risks.
Rapamycin, initially developed for medical use, is gaining attention as a potential longevity drug. Experts highlight its ability to extend lifespan in various animal models, with some longevity physicians prescribing it off-label to healthy adults. The drug's mechanism involves inhibiting the mTOR pathway, which regulates cellular growth and maintenance processes linked to aging.
While animal studies demonstrate significant lifespan increases, up to 60% in mice, human evidence is still emerging and requires more research. Current human data is considered incomplete, with limited short-term studies focused on specific conditions rather than aging itself. Therefore, it is viewed as an experimental intervention.
Using rapamycin without medical supervision carries considerable risks. As an immunosuppressant, it can increase infection susceptibility, impair healing, and affect metabolism. Experts strongly advise consulting a health practitioner before considering such treatments due to unknown optimal dosages and long-term safety in healthy populations.
